GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » Price-to-Funds-From-Operations

Kadimastem (XTAE:KDST) Price-to-Funds-From-Operations : (As of Apr. 27, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kadimastem Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Kadimastem (XTAE:KDST) Business Description

Industry
Traded in Other Exchanges
Address
Pinchas Sapir 7, Weizmann Science Park, Nes-Ziona, ISR
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.